Neurocrine Biosciences, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 0.12x
Net debt / equity: 0.04x
Debt / assets: 0.08x
Debt / EBITDA: 0.42x
Net debt / EBITDA: 0.15x

Liquidity & coverage

Current ratio: 2.93x
Quick ratio: 2.85x
Cash ratio: 1.58x
Interest coverage: —
EBITDA / interest: —
Working capital: $1.6B

Cash & dividend

FCF / debt: 2.05x
Cash flow / debt: 2.13x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.